(Q37822219)

English

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

scientific article published on 17 December 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

0 references

chronic obstructive pulmonary disease

0 references

1 reference

based on heuristic

inferred from title

systems biology

1 reference

based on heuristic

inferred from title

author name string

Alvar Agusti

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Patricia Sobradillo

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Bartolomé Celli

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

language of work or name

0 references

publication date

17 December 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

American Journal of Respiratory and Critical Care Medicine

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

183

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1129-1137

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

COPD, a multicomponent disease: implications for management

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Immunology of asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The nature of small-airway obstruction in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Immunologic aspects of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The COPD genetic association compendium: a comprehensive online database of COPD genetic associations

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Variants in FAM13A are associated with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Systems biology. Life's complexity pyramid

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Network biology: understanding the cell's functional organization

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Genomewide association studies and assessment of the risk of disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The human disease network

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Human disease classification in the postgenomic era: a complex systems approach to human pathobiology

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

A dynamic network approach for the study of human phenotypes

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

An integrative systems biology approach to understanding pulmonary diseases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Systems medicine: the future of medical genomics and healthcare

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Bridging the gap between systems biology and medicine

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The human phenome project

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Clinical COPD phenotypes: a novel approach using principal component and cluster analyses

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Proportional classifications of COPD phenotypes.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Molecular biomarkers for quantitative and discrete COPD phenotypes.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Outcomes and markers in the assessment of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Genetic epidemiology of COPD (COPDGene) study design

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

C-reactive protein in patients with COPD, control smokers and non-smokers

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Profiling serum biomarkers in patients with COPD: associations with clinical parameters

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Integrating the MicroRNome into the study of lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Secretory mechanisms and intercellular transfer of microRNAs in living cells

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Emergence of Scaling in Random Networks

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Lethality and centrality in protein networks

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Hubs in biological interaction networks exhibit low changes in expression in experimental asthma

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The Sequence of the Human Genome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

A unifying view of 21st century systems biology

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Chronic lung diseases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Maximal extraction of biological information from genetic interaction data

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

A network-based analysis of systemic inflammation in humans

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Using systems biology to simplify complex disease: immune cartography

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The implications of human metabolic network topology for disease comorbidity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

The impact of cellular networks on disease comorbidity

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Chronic Obstructive Pulmonary Disease Biomarker(s) for Disease Activity Needed—Urgently

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201009-1414PP

21 January 2018

Identifiers

10.1164/RCCM.201009-1414PP

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37822219&oldid=2221333438"